Cargando…
Venetoclax联合低剂量阿糖胞苷治疗不耐受强化化疗的初治急性髓系白血病患者：一项Ⅲ期随机、安慰剂对照试验中中国队列结果
OBJECTIVE: To investigate the safety and efficacy of venetoclax with low-dosecytarabine（LDAC）in Chinese patients with acute myeloid leukemia（AML）who are unable to tolerateintensive induction chemotherapy. METHODS: Adults ≥ 18 years with newly diagnosed AML who wereineligible for intensive chemothera...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120118/ https://www.ncbi.nlm.nih.gov/pubmed/33979972 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.04.004 |